Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | FASN | P49327 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 6/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 3/20 | 0.35 |
| ▸ | CNR2 | P34972 | 3/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9339647 | 1.00 | TSHR (0.45) | TSHRALDH1A1FASNFAAHTRPV1 | |
| SCHEMBL19973929 | 1.00 | TSHR (0.45) | TSHRALDH1A1FASNFAAHTRPV1 | |
| SCHEMBL19973928 | 1.00 | TSHR (0.45) | TSHRALDH1A1FASNFAAHTRPV1 | |
| SCHEMBL18837544 | 1.00 | TSHR (0.45) | TSHRALDH1A1FASNFAAHTRPV1 | |
| SCHEMBL25178035 | 1.00 | TSHR (0.45) | TSHRALDH1A1FASNFAAHTRPV1 | |
| SCHEMBL18837543 | 1.00 | TSHR (0.45) | TSHRALDH1A1FASNFAAHTRPV1 | |
| SCHEMBL25171253 | 1.00 | TSHR (0.45) | TSHRALDH1A1FASNFAAHTRPV1 | |
| SCHEMBL29284542 | 1.00 | TSHR (0.45) | TSHRALDH1A1FASNFAAHTRPV1 | |
| SCHEMBL21694684 | 1.00 | TSHR (0.45) | TSHRALDH1A1FASNFAAHTRPV1 | |
| SCHEMBL26932927 | 1.00 | TSHR (0.45) | TSHRALDH1A1FASNFAAHTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118201905-A | Cationic lipid | 武田药品工业株式会社 | 2024-06-14 | — | — | CN | disclosed |
| CN-117304048-A | Cationic lipid | 武田药品工业株式会社 | 2023-12-29 | — | — | CN | disclosed |
| CN-112639111-B | Method for transfecting cardiomyocytes using cationic lipids | 国立大学法人京都大学 | 2023-07-21 | — | — | CN | disclosed |
| WO-2023085299-A1 | CATIONIC LIPID | 武田薬品工業株式会社 | 2023-05-19 | — | — | WO | disclosed |
| US-20220145329-A1 | METHOD FOR TRANSFECTION INTO CARDIOMYOCYTES USING CATIONIC LIPID | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2022-05-12 | — | — | US | disclosed |
| EP-3842538-A1 | METHOD FOR TRANSFECTION INTO CARDIOMYOCYTES USING CATIONIC LIPID | Kyoto University (JP) | 2021-06-30 | — | — | EP | disclosed |
| EP-3835287-A1 | CATIONIC LIPID | Takeda Pharmaceutical Company Limited (JP) | 2021-06-16 | — | — | EP | disclosed |
| CN-112639111-A | Method for transfecting cardiomyocytes using cationic lipids | 国立大学法人京都大学 | 2021-04-09 | — | — | CN | disclosed |
| CN-112533893-A | Cationic lipid | 武田药品工业株式会社 | 2021-03-19 | — | — | CN | disclosed |
| WO-2020032185-A1 | METHOD FOR TRANSFECTION INTO CARDIOMYOCYTES USING CATIONIC LIPID | 国立大学法人京都大学 | 2020-02-13 | — | — | WO | disclosed |
| WO-2020032184-A1 | CATIONIC LIPID | 武田薬品工業株式会社 | 2020-02-13 | — | — | WO | disclosed |